The Role of Platelet Reactivity and Genotype Testing in the Prevention of Atherothrombotic Cardiovascular Events Remains Unproven

被引:49
作者
Krishna, Vamsi [1 ]
Diamond, George A. [1 ]
Kaul, Sanjay [1 ]
机构
[1] Cedars Sinai Med Ctr, Div Cardiol, Los Angeles, CA 90048 USA
关键词
PERCUTANEOUS CORONARY INTERVENTION; CLOPIDOGREL-TREATED PATIENTS; OF-FUNCTION POLYMORPHISM; PROTON PUMP INHIBITORS; FOUNDATION TASK-FORCE; CYP2C19; GENOTYPE; STENT THROMBOSIS; ANTIPLATELET THERAPY; CLINICAL-EFFICACY; GENETIC-VARIANTS;
D O I
10.1161/CIRCULATIONAHA.111.075242
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1288 / 1303
页数:16
相关论文
共 75 条
[21]   Use and misuse of the receiver operating characteristic curve in risk prediction [J].
Cook, Nancy R. .
CIRCULATION, 2007, 115 (07) :928-935
[22]   Glycoprotein IIb/IIIa Inhibitors Improve Outcome After Coronary Stenting in Clopidogrel Nonresponders A Prospective, Randomized Study [J].
Cuisset, Thomas ;
Frere, Corinne ;
Quilici, Jacques ;
Morange, Pierre-Emmanuel ;
Mouret, Jean-Philippe ;
Bali, Laurent ;
Moro, Pierre-Julien ;
Lambert, Marc ;
Alessi, Marie-Christine ;
Bonnet, Jean Louis .
JACC-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (06) :649-653
[23]   WHAT PRICE PERFECTION - CALIBRATION AND DISCRIMINATION OF CLINICAL-PREDICTION MODELS [J].
DIAMOND, GA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (01) :85-89
[24]   Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study [J].
Fontana, P. ;
James, R. ;
Barazer, I. ;
Berdague, P. ;
Schved, J. -F. ;
Rebsamen, M. ;
Vuilleumier, N. ;
Reny, J. -L. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (08) :1664-1666
[25]   ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome [J].
Frere, Corinne ;
Cuisset, Thomas ;
Quilici, Jacques ;
Camoin, Laurence ;
Carvajal, Joseph ;
Morange, Pierre Emmanuel ;
Lambert, Marc ;
Juhan-Vague, Irene ;
Bonnet, Jean-Louis ;
Alessi, Marie-Christine .
THROMBOSIS AND HAEMOSTASIS, 2007, 98 (04) :838-843
[26]   Thrombotic events in high risk patients are predicted by evaluating different pathways of platelet function [J].
Gori, Anna Maria ;
Marcucci, Rossella ;
Paniccia, Rita ;
Giusti, Betti ;
Fedi, Sandra ;
Antonucci, Emilia ;
Buonamici, Piergiovanni ;
Antoniucci, David ;
Gensini, Gian Franco ;
Abbate, Rosanna .
THROMBOSIS AND HAEMOSTASIS, 2008, 100 (06) :1136-1145
[27]   When is a new prediction marker useful?: A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk [J].
Greenland, P ;
O'Malley, PG .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (21) :2454-2456
[28]   The effect of elinogrel on high platelet reactivity during dual antiplatelet therapy and the relation to cyp 2c19*2 genotype: first experience in patients [J].
Gurbel, P. A. ;
Bliden, K. P. ;
Antonino, M. J. ;
Stephens, G. ;
Gretler, D. D. ;
Jurek, M. M. ;
Pakyz, R. E. ;
Shuldiner, A. R. ;
Conley, P. B. ;
Tantry, U. S. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (01) :43-53
[29]   Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies The RESPOND Study [J].
Gurbel, Paul A. ;
Bliden, Kevin P. ;
Butler, Kathleen ;
Antonino, Mark J. ;
Wei, Cheryl ;
Teng, Renli ;
Rasmussen, Lars ;
Storey, Robert F. ;
Nielsen, Tonny ;
Eikelboom, John W. ;
Sabe-Affaki, Georges ;
Husted, Steen ;
Kereiakes, Dean J. ;
Henderson, David ;
Patel, Dharmendra V. ;
Tantry, Udaya S. .
CIRCULATION, 2010, 121 (10) :1188-1199
[30]   Effect of Clopidogrel on the Rate and Functional Severity of Stroke Among High Vascular Risk Patients A Prespecified Substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) Trial [J].
Hankey, Graeme J. ;
Hacke, Werner ;
Easton, J. Donald ;
Johnston, S. Claiborne ;
Mas, Jean-Louis ;
Brennan, Danielle M. ;
Bhatt, Deepak L. ;
Fox, Keith A. A. ;
Topol, Eric J. .
STROKE, 2010, 41 (08) :1679-1683